Patient access to biosimilars: the power of UNICORN™ software on process automation and DoE

Patient access to biosimilars: Alvotech discusses the power of UNICORN™ software on process automation and DoE

As global biopharma evolves, patient access to affordable and approved biosimilars and therapeutics is critical to improve lives. Learn how UNICORN single-platform control software supports Design of Experiments (DoE) application, as well as multiple process scales and techniques to help streamline operations and the process transfers throughout the development cycle.

Learn how Cytiva UNICORN™ software can help: https://cytiva.link/pzbpr

Learn more about Alvotech: https://www.alvotech.com/